A Two-Part, Single-Blind, Phase 3 Study Evaluating the Efficacy and Safety of Patiromer for the Treatment of Hyperkalemia (OPAL)

Clinical trial NCT01810939 · COMPLETED

Trial details

NCT number: NCT01810939
Sponsor: Relypsa, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Kidney Disease (CKD)Hyperkalemia (HK)

Start date: 2013-02-01
Primary completion: 2013-07-01
Enrollment: 243

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.